In our method, the cells or tissues of interest are cryogenically milled into micrometer-sized particles to maximize the efficiency of solvent extraction of the protein complexes 12 . The resulting solubilized complexes are affinity captured on magnetic beads conjugated with anti-GFP V H H nanobodies 13 , which we have engineered to preclude reaction with amine-specific chemical cross-linking reagents such as disuccinimidyl suberate (DSS); these nanobodies are based on previously described subnanomolaraffinity LaG-16 (ref. 9 ) and 3K1K or GBP1 (PDB 3K1K) 14 reagents, but with lysine residues substituted by either arginine or glutamine residues ( Supplementary Figs. 1 and 2 ). Because these substitutions are distal from the nanobodies' GFP-binding epitopes, they do not alter their binding affinities (Supplementary Figs. 1b and 2b-d). These nanobodies are also chemically treated to minimize residual reactivity (for example, at their amino termini) toward amine cross-linkers. The resulting high-affinity, 'cross-linking inert' reagents allow rapid, efficient affinity capture of complexes followed by on-bead cross-linking, without cross-linking of the complexes to the bead-immobilized nanobodies. This property enables efficient removal of the cross-linked complex from the nanobody-conjugated beads ( Fig. 1 and Supplementary Fig. 3 ), circumventing the otherwise formidable challenge of efficiently proteolyzing the highly rigid cross-linked complexes while they are still chemically conjugated to the beads. This 'on-bead' crosslinking strategy also simplifies sample handling while providing a means for the removal of complexes that are not cleavable from the resin, including most GFP-transgenic systems.
After on-bead cross-linking by DSS, the complexes are eluted from the nanobody beads by denaturing buffer, resolved on SDS-PAGE and proteolyzed in-gel by trypsin (Online Methods). The proteolyzed products are fractionated, and the cross-linked peptides are identified by MS. Finally, the resulting distance restraints are used to depict architectures or generate structural models of the protein complexes 15 .
To assess our overall workflow, we examined the Saccharomyces cerevisiae exosome, whose core structure has been elucidated at atomic resolution 16, 17 . Exosomes are multiprotein assemblies that process and degrade cellular RNA 18 . An 11-subunit exosome complex (exo11) forms a barrel-like structure composed of two stacked rings: an upper trimeric ring of RNA binding domain-containing proteins (Rrp40, Rrp4 and Csl4), and a lower hexameric ring of PH-domain proteins (Rrp45, Rrp46, Rrp42, Rrp43, Mtr3 and Ski6), as well as two catalytic subunits (Rrp6 and Rrp44).
We affinity-captured the complex via a genomically GFP-tagged component of the core (RRP46-GFP). SDS-PAGE and MS analysis identified the 11 components of exo11, as well as two stoichiometric it remains particularly problematic to define the structures of native macromolecular assemblies, which are often of low abundance. here we present a strategy for isolating complexes at endogenous levels from GfP-tagged transgenic cell lines. using cross-linking mass spectrometry, we extracted distance restraints that allowed us to model the complexes' molecular architectures.
Chemical cross-linking with mass spectrometric readout (CX-MS) is emerging as particularly useful for providing distance restraints between amino acid residues in protein assemblies. Such data can be readily combined with other structural information to provide 'integrative' structural models 1,2 . Because the majority of such studies rely on recombinant protein complexes [3] [4] [5] [6] , the reach and application of CX-MS would be greatly extended if the technique were optimized for the analysis of native protein complexes isolated directly from their endogenous cellular milieus 7, 8 . Major challenges to the analysis of such complexes relate to their often low abundance (necessitating ultrahigh-affinity reagents for their efficient and pristine capture 9 ), their dynamic nature and their compositional and structural heterogeneity. Here we present a pipeline that incorporates ultrahigh-affinity reagents tuned to perform optimally with improved CX-MS analyses, in order to provide the requisite sensitivity to analyze macromolecular assemblies expressed at native levels.
Our pipeline (Fig. 1) was tuned for affinity capture of GFPtagged protein complexes (with the tagged proteins expressed under control of their endogenous promoters) to take advantage of this most widely used tag for visualizing proteins in vivo. The extensive worldwide resource of transgenic organisms and animals that contain GFP-tagged proteins should be of great utility in this application 10, 11 . subunits (Lrp1 and Ski7) and a substoichiometric component (Mpp6) that were not studied by X-ray crystallography 18 ( Fig. 2a and Supplementary Table 1 ). The resulting connectivity map (Fig. 2b) largely recapitulated the previously determined architecture of the complex. For example, the catalytic subunit Rrp6 was located proximal to Rrp43, Csl4 and Rrp4, predominantly via its C-terminal domain (CTD) (residues 421-676), whereas its Nterminal domain (NTD) (residues 45-379) was extensively crosslinked to Lrp1 to potentially form a heterodimer 19 (Fig. 2b,c) . The other catalytic subunit, Rrp44, was cross-linked to the periphery of the hexameric (lower) ring via Rrp45 and Ski6. Interestingly, the fact that the majority of the Rrp6 and Ski7 intersubunit cross-links shared identical lysine residues on Rrp4, Csl4 and Rrp43 (Fig. 2c) suggests that Rrp6 and Ski7 are potentially mutually exclusive and exist in two different complexes 16 . Consistent with this notion, GFP localization and affinity capture coupled to MS ( Fig. 2c and Supplementary Fig. 4) showed that Rrp6-Lrp1-Mpp6-exo10 (exo11 minus Rrp6) formed a nucleus-localized complex, whereas the Ski7-exo10 complex was restricted to the cytoplasm (Fig. 2d,  Supplementary Fig. 5 and Supplementary Tables 2 and 3) .
To evaluate the cross-link data, we measured the Euclidean Cα-Cα distances between cross-linked lysine residues in the published X-ray structure of exo10 and the CTD of Rrp6 (PDB 4IFD), as well as in the structures of the heterotrimer Rrp45, Ski6 and Rrp44 (ref. 20) (PDB 2WP8). We found that 34% of the cross-linking data could be mapped to the X-ray structures ( Supplementary Fig. 6 and Supplementary Table 4) . Of these, >90% spanned ≤30 Å (the expected maximum reach), whereas four cross-links in PDB 4IFD and three in PDB 2WP8 mapped to much longer distances in the X-ray structures (44-65 Å) (Fig. 2e,f and Supplementary Fig. 7) . Notably, all of these seemingly 'violated' cross-links (red) were located on Rrp44 (Fig. 2g,h) , the essential catalytic subunit that exhibits both 3′-5′ RNA exoRNase and endoRNase activities, supporting the notion that this enzyme is highly dynamic, forming different conformers in the cell 21 .
The relatively rich information about cross-linking of nuclear Rrp6-Lrp1 and cytosolic Ski7 to the exo10 core allowed us to utilize integrative modeling 15 to determine the architectures of these subcellular-specific exosome complexes (Online Methods). As shown in Figure 2i , the nuclear Rrp6-Lrp1 heterodimer is localized on top of the trimeric ring, which likely allows recruitment of RNA substrates for Rrp6 exoRNase activity. The position of the corresponding cytosolic component Ski7 with respect to exo10 was resolved with an average residue precision of ~9 Å (root-mean-square fluctuation; Supplementary Fig. 8 and Online Methods); it docked on the upper ring with its C-terminal GTPase domain above Csl4 and Rrp4, close to the central channel (RNA entrance) (Fig. 2j) . Intriguingly, its disordered NTD (Fig. 2j) (residues 90-264) was curved like a necklace that wrapped around Csl4 and the N terminus of Rrp4 before emerging on top of the upper ring, where it connected to the folded GTPase domain, reminiscent of the architecture of the nuclear Rrp6 CTD, but with the opposite chirality.
To assess the utility of our approach for examining low-abundance native complexes (tens to hundreds of copies per cell) 22, 23 , we studied the S. cerevisiae anaphase-promoting complex (also known as the cyclosome (APC/C)), a ubiquitin E3 ligase essential for cell cycle progression 24 . The architecture of the yeast APC/C (13 unique polypeptides) with its cofactor Cdh1 bound to a D-box peptide has been studied by cryo-electron microscopy and solved using recombinant overexpressed proteins at a resolution of ~10 Å (ref. 22 ) and recombinant human APC/C at 7.4 Å, resulting in characterization of the packing of secondary-structure segments for all subunits 25 .
We affinity-captured the stoichiometric subunits of the endogenous complex together with the substoichiometric component Cdh1 (Fig. 3a and Supplementary Table 5) . The resulting connectivity map ( Fig. 3b and Supplementary Table 6 ) was consistent with the architecture revealed by electron microscopy 22, 25 . For example, the tetratricopeptide repeat (TPR) domain-containing proteins (Cdc27, Cdc16 and Cdc23) were extensively cross-linked, revealing the TPR lobe to which accessory subunits (Apc13, Cdc26 and the yeast-specific subunit Apc9) were bound. Cross-links within the base/platform module (Apc1, Micrometer-sized particle figure 1 | Workflow for isolation and CX-MS analysis of GFP-tagged protein complexes. Cells or animal tissues are cryogenically milled into micrometer-sized particles (powders), which are dissolved in appropriate buffers to efficiently extract the proteins while preserving the architectures of the native protein assemblies. The GFP-tagged protein complex (5-15 µg) is then affinity-captured by ultrahigh-affinity, non-cross-linkable nanobody-conjugated magnetic beads. The protein complex is on-bead cross-linked by DSS, after which the cross-linked complex is eluted by heated LDS (lithium dodecyl sulfate) denaturing buffer and separated by SDS-PAGE electrophoresis. The efficiently cross-linked complex is in-gel proteolyzed to generate the cross-linked peptides, which are identified by high-resolution MS. The resulting information can be translated into residue-specific spatial restraints for computing integrative structural models.
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Apc2, Apc4 and Apc5) were prevalent. The TPR lobe and base modules were bridged by the cross-links Cdc23-Apc1, Cdc16-Apc1 and Cdc27-Apc2, defining a structure that seemed to be conserved from yeast to human. Another yeast-specific subunit, Mnd2, was cross-linked to both the TPR lobe (Cdc23 and Cdc16) and the scaffold (Apc4) via its N-terminal region, further connecting the two modules.
Although intersubunit cross-links provide the most useful distance restraints, certain intrasubunit cross-links may also reveal the architecture of a single subunit; for example, crosslinks between the C-terminal and mid-domains of Apc1 constrain these regions so that they are spatially close and proximal to the central region of Apc2 (as in the high-resolution human APC/C structure). We also identified 'same-residue' cross-links on Cdc27 and Cdc16 ( Supplementary Fig. 9 and Supplementary Table 7) , consistent with homodimer formation 25 .
Finally, we explored the possibility of architecturally dissecting native GFP-tagged complexes isolated from a single transgenic mouse (Mus musculus) liver, investigating Beclin 1-associated complexes, which are central effectors of autophagy known to regulate aging and neurological disorders 26 . Despite the biological importance of these complexes, their overall architectures remain to be eludicated [27] [28] [29] . We applied our pipeline to map the arrangement of the complexes' seven major subunits that we had previously affinity isolated 30, 31 (Fig. 3c,d and Supplementary Tables 7 and 8).
Multiple cross-links were identified between Beclin 1-EGFP and its binding partner Vps34 through the coiled-coil domain of Beclin 1 (residues 142-267) and the N-terminal C2 domain of Vps34 (residues 1-255). Cross-links also showed that the C2 domain of Vps34 and the Vps15 CTD are in close proximity. Interestingly, Atg14L and Uvrag shared many intersubunit cross-links to the same lysine residues on Beclin 1, Vps34 and Vps15 triad, indicating that Atg14L and Uvrag interact in a mutually exclusive manner with the triad to form two different complexes 32 (Fig. 3c,d ).
In summary, our approach yielded useful distance restraints in three exemplary low-to medium-abundance multisubunit complexes and elucidated complexes displaying heterogeneity, which is common in endogenous assemblies. Together with integrative modeling, this approach provides an effective means to model structures of proteins that contain extensive disordered or flexible regions, which present a problem for most other structural approaches.
Note added in proof: While this manuscript was in production, Makino et al. 33 33 . 
npg online methods Cloning, purification and chemical conjugation of anti-GFP V H H nanobodies. Codon-optimized DNA sequences of lysineless V H H nanobodies were synthesized (Genscript) and cloned into pET21-pelB-V H H vector using BamHI and XhoI restriction sites (Supplementary Note). A flexible linker sequence of GGGSGGC was inserted at the carboxyl terminus of the proteins to allow chemical conjugation and proper folding of the proteins. The nanobodies were expressed and were purified by nickelnitrilotriacetic acid beads as previously described 9 . Purified nanobodies were then conjugated to epoxy-activated Dynabeads 34 (Invitrogen). For each 1 mg of epoxyl Dynabeads, ~5 µg of nanobodies was used for the conjugation. The lysineless nanobody beads (LaG-16-2K/R or 3K1K-3K/R) were further chemically blocked by 0.5 mM DSS for 30-45 min at 25 °C with constant agitation on a shaker and were subsequently quenched by a 100 mM final concentration of Tris-HCl (pH 8). The reagents were stored at 4 °C and were used within 3 weeks of conjugation.
Comparison of efficacies of three different anti-GFP affinity reagents for on-bead cross-linking.
Equal amounts of llama polyclonal antibody (Poly, generated in-house), wild-type LaG-16 and lysineless LaG-16-2K/R (2K/R) nanobodies were conjugated in parallel to epoxy magnetic beads. The antibody-conjugated magnetic beads were pretreated with DSS cross-linker to block residual reactive amines and were then used for the affinity isolation of the APC/C. The isolated complex was on-bead crosslinked by 0.1 mM DSS for 25 min and eluted by hot LDS buffer. The complex was subjected to SDS-PAGE electrophoresis; gel regions corresponding to the GFP-tagged Cdc16 (~70-160 kDa for non-cross-linked Cdc16 and >350 kDa for cross-linked Cdc16) were excised from the gel and digested by trypsin.
The purified peptides were analyzed by an Orbitrap Fusion mass spectrometer coupled online to the Easy LC system (Thermo). For each analysis, peptides corresponding to ~20-40 ng of the purified complex were loaded onto an Easy-Spray column heated at 35 °C (C18, 3-µm particle size, 200-Å pore size, and 50 µm × 15 cm; Thermo Fisher) and eluted using a 25-min liquid chromatography gradient (2% B-7% B, 0-3 min; 7% B-42% B, 3-21 min; 42% B-100% B, 21-25 min; mobile phase A consisted of 0.1% formic acid (FA), and mobile phase B consisted of 0.1% FA in acetonitrile (ACN)). The flow rate was ~325 nl/min. The instrument was operated in the data-dependent mode, where the top eight most abundant ions were fragmented by higher energy collisional dissociation (HCD) (normalized HCD energy, 30) and analyzed in the Orbitrap mass analyzer. The target resolution for MS1 was 60,000, and for MS2 it was 15,000. Peptides (300-1,500 m/z) with charge state of 2-5 were isolated by the ion trap (isolation window, 1.8 Th) and detected by the Orbitrap analyzer. The experiments were repeated three times, and each repeated sample was measured three times to minimize the LC-MS analytical variations.
For label-free quantification, the raw data were searched against the yeast ORF database (01/05/2010) and quantified by MaxQuant 35 (version 1.5). The search parameters included the following: initial MS accuracy, <20 p.p.m.; main search MS accuracy tolerance, <4.5 p.p.m.; cysteine carbamidomethyl as a fixed modification; and protein N-terminal acetylation and methionine oxidation as variable modifications. A maximum of two trypsin missed-cleavage sites was allowed. More than 30 unique peptides from Cdc16 were identified and used for the quantification. For label-free quantification, ion intensities of Cdc16 (which in essence represents the relative signals of the complex) from the cross-linked APC/C (isolated by three different anti-GFP affinity reagents) were normalized by those of input signals; the resulting ratios were normalized to 2K/R and are plotted in Supplementary  Figure 3. K d measurements by surface plasmon resonance (SPR). SPR measurements were obtained on a Proteon XPR36 Protein Interaction Array System (Bio-Rad). Recombinant GFP was immobilized on a ProteOn GLC sensor chip. The chip surface was first activated with 50 mM sulfo-NHS and 50 mM EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide), run at a flow rate of 30 µl/min for 300 s. The ligand was then diluted to 5 µg/ml in 10 mM sodium acetate, pH 5.0, and injected at 25 µl/min for 180 s. Finally, the surface was deactivated by 1 M ethanolamine-HCl (pH 8.5) run at 30 µl/min for 300 s. This led to immobilization of approximately 200 response units of ligand.
We determined the K d values of recombinant nanobodies by injecting four concentrations of each protein, in triplicate, with a running buffer of 20 mM Na-HEPES, pH 8.0, 150 mM NaCl, 0.01% Tween-20. Proteins were injected at 100 µl/min for 90 s, followed by a dissociation time of 660 s. Between injections, residual bound protein was eliminated by regeneration with 4.5 M MgCl 2 in 10 mM Tris-HCl, pH 7.5, run at 100 µl/min for 90 s. Binding sensorgrams from these injections were processed and analyzed using the ProteOn Manager software. Binding curves were fit to the data with a Langmuir model using grouped k a , k d and R max values.
GFP transgenic strains, cell culturing and cryogenic grinding of yeast cells and mouse liver. The GFP-tagged S. cerevisiae strains of RRP6 (YOR001W), SKI7 (YOR076C) and RRP46 (YGR095C) were purchased from Invitrogen. The GFP-CDC16-3 × Flag-His6 (YKL022C) strain (MATα BY4742) was generated as previously described 36 . All yeast cells were cultured in yeast extract peptone dextrose medium (MP Biomedicals) at 30 °C to a density of 3 × 10 7 to 4 × 10 7 cells/ml before harvesting. The Becn1-EGFP/+ bacterial artificial chromosome (BAC) transgenic mice express Beclin 1-EGFP under endogenous transcriptional control 30 . One mouse (female, C57BL/6 background, age 5 months) was killed; its liver was collected and immediately frozen in liquid nitrogen for storage. Yeast strains and the mouse liver were cryogenically milled with a planetary ball mill 12, 37 (Retsch PM 100), and the cryogenic powders were stored at −80 °C until use. Animal procedures were approved by the Institutional Animal Care and Use Committees at the University of Kentucky, where the mouse was housed.
Fluorescence microscopy. S. cerevisiae strains RRP6-GFP (YOR001W) and SKI7-GFP (YOR076C) were grown to mid-log phase, stained with 2.5 µg/ml DAPI for 20 min, washed with PBS and visualized in vivo by a fluorescence microscope (Axioplan 2, Carl Zeiss) equipped with a cooled charge-coupled device (CCD) camera (ORCA-ER, Hamamatsu). The images were analyzed with Openlab software (PerkinElmer) and processed using Adobe Photoshop CS5 (Adobe).
npg Affinity capture of protein complexes. To identify the compositions of the yeast exosome and APC/C, we dissolved 200 mg and 500 mg of yeast grindate powder in 0.75 ml and 1.5 ml yeast lysis buffer, respectively (100 mM Na-HEPES, pH 7.9, 0.2% Tween-20, 350 mM sodium citrate, protease inhibitor cocktail (Roche)) and briefly sonicated the mixture on ice. The protein extracts were centrifuged at 14,000 r.p.m. for 12 min, and the supernatants were collected. We affinity-isolated the protein complexes by adding ~2 mg of lysineless nanobody-conjugated Dynabeads to the supernatant for 30 min (exosome complex) or 60 min (APC/C) at 4 °C on a rotating wheel. The beads were then washed four times with 0.5-1 ml of yeast pullout buffer and collected using a magnetic stand.
To identify the Beclin 1-EGFP complex, we dissolved ~400 mg of the mouse liver grindate powder in 1 ml of pullout buffer (100 mM Na-HEPES, pH 7.9, 0.2% Tween-20, 150 mM sodium chloride, 350 mM sodium citrate, and protease inhibitor cocktail) and briefly sonicated it on ice. The protein extract was centrifuged at 14,000 r.p.m. for 20 min, and the supernatant was transferred and incubated with ~2 mg of the nanobody-conjugated Dynabeads for ~2 h at 4 °C on a rotating wheel. The beads were washed four times and collected using a magnetic stand before elution.
On-bead crosslinking. We affinity-isolated several hundred nanograms of the complexes and cross-linked them at various concentrations of DSS cross-linker to empirically decide the optimal reaction conditions-that is, the minimal concentration of cross-linker that would enable all component proteins to migrate to the high-molecular-weight regions in the gel ( Supplementary  Fig. 10 ). We used ~40 mg of the nanobody-Dynabeads (3K1K-3K/R or Lag-16-2K/R) to isolate the protein complexes for CX-MS analyses from 3-4 g yeast grindate powder of Rrp46-GFP (exosome), ~12-15 g grindate powder of GFP-Cdc16 (APC/C), and the liver from a single transgenic GFP-Bcln1 mouse.
For CX-MS analysis, the purified complex (~5-15 µg) was on-bead cross-linked by isotopically labeled DSS (d0:d12 = 1:1, Creative Molecules) in 100 mM K-HEPES, pH 7.9. (We note that the isotopic label was not needed in the present experiments and can be omitted.) The cross-linked complex was quenched and eluted from the beads by LDS buffer (containing 100 mM DTT and 100 mM Tris-HCl, pH 8.5) at 85 °C for 10 min. The sample was cooled at room temperature for cysteine alkylation and separated by electrophoresis in either 4-12% Bis-Tris or 3-8% Tris-acetate SDS-PAGE gel (Invitrogen). SDS-PAGE allows (i) separation and enrichment of highly cross-linked materials (which run as high-molecular-weight products) to reduce the complexity of the digest and (ii) elimination of the detergents needed for solubilization of the complex, as well as chemical 'bleed' products from the magnetic beads, both of which can greatly reduce MS sensitivity. In addition, the presence of SDS helps denature and disperse the rigid, cross-linked complex, greatly facilitating proteolysis. We also tested an alternative possibility for obtaining distance restraints by treating whole-cell lysate with DSS cross-linker before affinity capture of the GFP-tagged protein complexes, but we found that this procedure provided insufficient intersubunit cross-linking yield to be useful while producing a high level of nonspecific protein background (Supplementary Fig. 11 and Supplementary Table 9 ). Affinity isolation of the yeast exosome complex from wholecell lysates cross-linked with different concentrations of DSS cross-linker. One gram of yeast cryomilled powder (Rrp46-GFP) was resuspended in 3.5 ml exosome complex buffer (100 mM Na-HEPES, pH 7.9/8.0, 0.2% Tween-20, 350 mM sodium citrate, protease inhibitor cocktail; Roche). Cell lysate was centrifuged at 13,000-14,000 r.p.m. for 15 min, and the supernatant was collected. Equal amounts of the soluble whole-protein lysate were then cross-linked for 2 h at 4 °C by different concentrations of DSS cross-linker (0, 0.04, 0.2, 1 and 5 mM (because of the solubility of DSS, we did not intend to further increase its concentration in the whole-cell lysate)). After cross-linking of the whole-protein lysates, the reaction was quenched by 50 mM Tris buffer (final concentration). Cross-linked protein lysates were then centrifuged to remove the precipitated proteins, and the supernatants were collected for affinity capture of the exosome complex (using the protocol described above). Approximately 0.5 mg of 2K/R nanobody-conjugated magnetic beads was used for each affinity capture (from ~200 mg of cryogenic yeast powder).
The affinity-isolated proteins were loaded onto a 4-12% Bis-Tris SDS-PAGE gel and digested by trypsin. After proteolysis, the purified peptides were analyzed by LC-MS (two analytical replicates; a 25-min LC gradient was used for each analysis) with a Q Exactive (QE) Plus mass spectrometer (Thermo). The proteins were identified by X! Tandem (http://www.thegpm.org/tandem/), and the relative amounts were quantified by peptide spectra counts using unique peptide identifications (Supplementary Table 9 ). Proteolysis. The cross-linked complex was digested in-gel with trypsin to generate cross-linked peptides. The gel region above 220 kDa was sliced, crushed into small pieces and incubated overnight with trypsin at a 1:20 (wt/wt) ratio in 50 mM ammonium bicarbonate buffer containing 0.1% Rapigest (Waters) at 37 °C. The cross-linked complex was then re-digested by a second bolus of the same amount of trypsin for 4 h. The digestion mixture was acidified by FA, and peptides were extracted twice by the addition of a stepwise gradient of ACN and vigorous shaking at room temperature. The peptide extracts were pooled and centrifuged at 13,000 r.p.m. for 10 min. The supernatant was collected, flash-frozen and lyophilized to ~30 µl. The peptide mixture was then reconstituted in 5% MeOH, 0.2% FA and desalted by a C18 SPE column (Waters). After lyophilization (to ~5 µl), the resulting peptides were reconstituted in 20 µl of a solution containing 30% ACN and 0.2% FA and fractionated by peptide size-exclusion chromatography 38 (Superdex Peptide PC 3.2/30, GE Healthcare) using off-line HPLC separation and an autosampler (Agilent Technologies). Two or three size-exclusion chromatography fractions covering the molecular mass range of ~2.5-8 kDa were collected and analyzed by LC-MS.
LC-MS analysis and MS data interpretation.
To characterize the composition of the affinity-captured material, we loaded a portion of the purified proteolytic peptides (corresponding to 100-200 ng of the purified complex) onto a self-packed PicoFrit column (5 cm × 75 µm inner diameter, 3 µm, New Objective). The column was packed with 5 cm of reversed-phase C18 material (3 µm porous silica, 200-Å pore size, Dr. Maisch). Mobile phase A consisted of 0.5% acetic acid, and mobile phase B consisted of 70% npg ACN with 0.5% acetic acid. The peptides were eluted in a linear LC gradient using an HPLC system (Agilent) and analyzed with an LTQ Velos Orbitrap Pro mass spectrometer (Thermo Fisher). The instrument was operated in the data-dependent mode, where the top 20 most abundant ions were fragmented by collisioninduced dissociation (normalized energy: 35) and analyzed in the linear ion trap. The target resolution for MS1 was 60,000. Other instrumental parameters included lock mass at 371.1012 Da and a minimal threshold of 3,000 to trigger an MS/MS event. Ion trap accumulation limits (precursors) were 1 × 10 5 and 1 × 10 6 , respectively, for the linear ion trap and Orbitrap.
Raw data from the affinity capture-MS experiments were converted to an mzXML file and searched online by X! Tandem For cross-link identifications, the purified peptides were dissolved in the sample loading buffer (5% MeOH, 0.2% FA) and analyzed by an LTQ Velos Orbitrap Pro mass spectrometer (for most analyses) or an Orbitrap QE Plus mass spectrometer (Thermo Fisher). For the analysis by the Velos Orbitrap mass spectrometer, the dissolved peptides were pressure-loaded onto a self-packed PicoFrit column with an integrated electrospray ionization emitter tip (360-µm outer diameter, 75-µm inner diameter with a 15-µm tip; New Objective). The column was packed with 8 cm of reversed-phase C18 material (3-µm porous silica, 200-Å pore size, Dr. Maisch). Mobile phase A consisted of 0.5% acetic acid, and mobile phase B consisted of 70% ACN with 0.5% acetic acid. The peptides were eluted in a 120-min LC gradient (8%-50% B, 0-93 min, followed by 50%-100% B, 93-110 min, and equilibrated with 100% A until 120 min) using an HPLC system (Agilent) and analyzed with an LTQ Velos Orbitrap Pro mass spectrometer. The flow rate was ~200 nL/min. The spray voltage was set at 1.9-2.3 kV. The capillary temperature was 275 °C, and ion transmission on Velos S lenses was set at 35%. The instrument was operated in the data-dependent mode, where the top eight most abundant ions were fragmented by HCD 40 (HCD energy: 27-29; 0.1-ms activation time) and analyzed in the Orbitrap mass analyzer. The target resolution was 60,000 for MS1 and 7,500 for MS2. Ions (370-1,700 m/z) with a charge state of >3 were selected for fragmentation. A dynamic exclusion of (15 s/2/55 s) was used. Other instrumental parameters included lock mass at 371.1012 Da, a mass exclusion window of 1.5 Th and a minimal threshold of 5,000 to trigger an MS/MS event. Ion trap accumulation limits (precursors) were 1 × 10 5 and 1 × 10 6 , respectively, for the linear ion trap and Orbitrap. For MS2, the Orbitrap ion accumulation limit was 5 × 10 5 . The maximum ion injection time for the Orbitrap was 500-700 ms. The QE Plus instrument was directly coupled to an Easy LC system (Thermo Fisher), and the experimental parameters used were similar to those for the Velos Orbitrap. The cross-linked peptides were loaded onto an Easy-Spray column heated at 35 °C (C18, 3-µm particle size, 200-Å pore size, 50 µm × 15 cm; Thermo Fisher) and eluted using a 120-min LC gradient (2%-10% B, 0-6 min, 10%-35% B, 6-102 min, 35%-100% B, 102-113 min, followed by equilibration, where mobile phase A consisted of 0.1% FA and mobile phase B consisted of 0.1% FA in ACN). The flow rate was ~300 nl/min. The spray voltage was 2.0 kV, and the top ten most abundant ions (with charge stages of 3-7) were selected and fragmented by HCD.
The cross-link raw data were transformed to MGF (Mascot generic format) by pXtract 1.0 and searched by pLink 41 using a FASTA database containing protein sequences of the identified subunits of each complex. For the exosome cross-linking database search, we included the budding yeast protein sequences of 14 known exosome subunits of Rrp44 (YOL021C), Rrp40 (YOL142W), Rrp46 (YGR095C), Rrp4 (YHR069C), Mtr3 (YGR158C), Csl4 (YNL232W), Rrp6 (YOR001W), Rrp45 (YDR280W), Ski7 (YOR076C), Rrp43 (YCR035C), Rrp42 (YDL111C), LRP1 (YHR081W), Ski6 (YGR195W), and Mpp6 (YNR024W), together with GFP and two other relatively abundant proteins (RPS3 (YNL178W) and PBP1 (YGR178C), which were identified with more than ten unique peptides by affinity-capture MS (Supplementary Table 1) ). For the APC/C crosslinking database search, we included the budding yeast protein sequences of 11 known APC/C subunits of Apc11 (YDL008W), Cdc16 (YKL022C), Cdc23 (YHR166C), Cdc27 (YBL084C), Swm1 (YDR260C), Apc1 (YNL172W), Apc2 (YLR127C), Apc4 (YDR118W), Apc5 (YOR249C), Doc1 (YGL240W), Cd26 (YFR036W), Mnd2 (YIR025W), Cdh1 (YGL003C), Apc9 (YLR102C), and GFP. For the mouse (M. musculus) Beclin 1 complex cross-linking database search, seven subunits (Beclin 1, Uvrag, Atg14L, Vps34, Vps15, Rubicon and Nrbf2) and the GFP protein were used. An initial MS1 search window of 5 Da was allowed to cover all isotopic peaks of the cross-linked peptides. The data were automatically filtered using a mass accuracy of MS1 ≤10 p.p.m. and MS2 ≤20 p.p.m. of the theoretical monoisotopic mass (A0) and other isotopic masses (A + 1, A + 2, A + 3, and A + 4) as specified in the software. Other search parameters included cysteine carboxymethylation as a fixed modification and methionine oxidation as a variable modification. A maximum of two trypsin missed-cleavage sites was allowed. The initial search results were obtained using the default 5% false discovery rate, estimated using a target-decoy search strategy. In our analysis, we treated the 5% false discovery rate as a rough initial filter of the raw data (albeit quite permissive). Next, we manually applied additional filters to remove potential false positive identifications from our data set 8 . For positive identifications, both peptide chains needed to contain four or more amino acids. In addition, for both peptide chains, the major MS/MS fragmentation peaks had to be assigned and follow a pattern that contained a continuous stretch of fragmentations. The cross-link maps were generated using AUTOCAD (Autodesk, Inc.; educational version). A comparison of cross-link data from the three different complexes is provided in Supplementary Table 10 .
Annotated high-resolution cross-link MS/MS spectra are provided in the Supplementary Data.
Relative stoichiometry quantification of affinity-captured exosome complexes by SYPRO Ruby stain. To quantify the relative stoichiometries of the complexes, we stained SDS-PAGE protein gels with SYPRO Ruby according to the manufacturer's instructions (Life Technologies) and visualized them using an LAS-3000 npg of the uncertainty parameters. The sampling was run on 64 replicas, with temperatures ranging between 1.0 and 2.5. Two independent sampling calculations were run for each complex, each one starting with a random initial configuration, for a total of 100,000 models per complex. We divided this set of models into two ensembles of the same size to assess sampling convergence (data not shown).
Analysis of the model ensemble. For each ensemble, the 500 best scoring models (i.e., the solutions) were grouped by k-means clustering 50 on the basis of the r.m.s. deviation between the Rrp6-Lrp1 and Ski7 subunits, after the superposition of the exo10 subunits. Two dominant clusters of similar structure were identified, with one cluster scoring better than the other. The precision of a cluster was calculated as the average r.m.s. deviation with respect to the cluster center (i.e., the solution that had the minimal r.m.s. deviation distance with respect to the others). The per-residue precision of a cluster (the root-mean-square fluctuation; Supplementary Fig. 9 ) was calculated as the average r.m.s. deviation distance of a residue in a solution with respect to the cluster center. The solutions of a cluster, superposed on the exo10 structure, were converted into the probability of any volume element being occupied by Rrp6, Ski7, Lrp1 and the GFP tag (localization density) 43, 45 .
Code availability. The scripts and models are available at http:// salilab.org/exosome.
